英国ICU中决定撤除或不予生命支持治疗与患者死亡率的相关性
该研究为英国国家临床数据库的回顾性观察队列,纳入2009年4月1日至2016年3月31日247个成人综合ICU收治的795,721例患者。其中92,327例(11.6%)做出了撤除或不予生命支持治疗的决定。研究者用多水平模型估计ICU层面实践变异,并将其作为工具变量分析该决策对180天死亡率的影响,估计边缘人群占总队列5.9%。结果显示,撤除或不予生命支持治疗的决定与边缘患者180天死亡率增加25.6%(95%CI 23.2-27.9%)相关。
要点
- 研究纳入英国247个成人综合ICU共795,721例患者,其中92,327例(11.6%)做出了撤除或不予生命支持治疗的决定。
- 采用ICU层面实践变异作为工具变量,估计边缘人群占总队列5.9%。
- 撤除或不予生命支持治疗的决定与边缘患者180天死亡率增加25.6%(95%CI 23.2-27.9%)相关。
- 该结果提示边缘患者从生命支持治疗中可能获得显著边际生存获益,决策时需权衡。
- 研究为回顾性观察设计,结论需前瞻性验证,不能直接作为床旁决策阈值。
适用人群与场景
- 英国参与Intensive Care National Audit and Research Center Case Mix Program的成人综合ICU患者,年龄为成人,入住时间为2009年4月1日至2016年3月31日。
诊断标准与关键阈值
- 原文未提及具体的诊断标准、评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及具体的红旗征或不能漏诊的情况。
研究设计与关键结果
- 研究类型:回顾性观察队列研究,基于英国国家临床数据库。
- 样本量与中心数:795,721例患者,247个成人ICU。
- 人群:2009年4月1日至2016年3月31日入住综合ICU的成人患者。
- 干预与对照:比较做出撤除或不予生命支持治疗决定与未做该决定的患者,利用ICU层面实践变异作为工具变量。
- 主要终点结果:撤除或不予生命支持治疗的决定与边缘患者180天死亡率增加25.6%(95%CI 23.2-27.9%)相关;边缘人群估计占总队列5.9%。
- 关键次要终点与不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:回顾性观察队列研究。
- 证据等级或推荐强度:原文未提及。
- 局限:回顾性设计、观察性数据、使用工具变量分析,可能存在残余混杂;原文未明确提及单中心或多中心限制(实际为多中心)。
对床旁实践的改变
- 该研究提示,在边缘患者中撤除或不予生命支持治疗的决定与180天死亡率增加相关,可能影响ICU床旁关于生命支持治疗决策的权衡,但需结合患者偏好和个体情况。
- 适用人群:英国成人综合ICU患者;不适用人群:原文未提及。
- 常见陷阱:不能将观察性关联直接视为因果,不能将25.6%的死亡率增加作为决策阈值;需注意工具变量分析的假设和局限性。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Differences in decisions to limit life-sustaining therapy are often supported by perceptions that patients receive unnecessary and expensive treatment which provide negligible survival benefit. However, the assumption behind those beliefs-that is, that life-sustaining therapy provides no significant marginal survival benefit-remains unproven. Our objective was to quantify the effects of variations in decisions to withdraw or withhold life-sustaining treatment on 180-day mortality in critically ill patients.
DESIGN: Retrospective observational cohort study of a national clinical database.
SETTING: Adult ICUs participating in the Intensive Care National Audit and Research Center Case Mix Program in the United Kingdom.
PATIENTS: Adult patients admitted to general ICUs between April 1, 2009, and March 31, 2016.
MEASUREMENTS AND MAIN RESULTS: During the study period, 795,721 patients were admitted to 247 ICUs across the United Kingdom. A decision to withdraw or withhold life-sustaining treatment was made for 92,327 patients (11.6%). A multilevel model approach was used to estimate ICU-level practice variation. The ICU-level practice variation was then used as an instrument to measure the effects of decision to withdraw or withhold life-sustaining treatment on 180-day mortality. The marginal population was estimated to be 5.9% of the total cohort. A decision to withdraw or withhold life-sustaining treatment was associated with a marginal increase in 180-day mortality of 25.6% (95% CI, 23.2-27.9%).
CONCLUSIONS: Decision to withdraw or withhold life-sustaining treatment in critically ill adults in the United Kingdom was associated with increased 180-day mortality in the marginal patients. The increased mortality from a decision to withdraw or withhold life-sustaining treatment in the marginal patient may be informative when establishing patients' preferences and evaluating the cost-effectiveness of intensive treatments.
参考来源
- Maharaj R, Harrison DA, Rowan K, et al. The Association Between the Decision to Withdraw Life-Sustaining Therapy and Patient Mortality in U.K. ICUs. Crit Care Med. 2022. PMID: 34402458. doi:10.1097/CCM.0000000000005306
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。